Market-Moving News for October 30th

DAY ONE BIOPHARMACEUTICALS, INC. +4.36% Pre
Deciphera Pharmaceuticals +4.01% Pre
VYNE THERAPEUTICS INC -0.45% Pre

DAY ONE BIOPHARMACEUTICALS, INC.

DAWN

17.46

17.46

+4.36%

0.00% Pre

Deciphera Pharmaceuticals

DCPH

17.36

17.36

+4.01%

0.00% Pre

VYNE THERAPEUTICS INC

VYNE

2.22

2.22

-0.45%

0.00% Pre

DCPH: 38% | Deciphera Pharma shares are trading higher after the company announced its study of patients with TGCT met its primary and secondary endpoint.

DAWN: 9.5% | Day One Biopharmaceuticals shares are trading higher after the company announced the FDA accepted its NDA for tovorafenib in relapsed or progressive pediatric low-grade glioma, granted priority review and assigned a PDUFA date of April 30, 2024.

VYNE: 72% | VYNE Therapeutics shares are trading higher after the company announced a private placement of $88 million and data from its Phase 1b trial evaluating once-daily dosing of VYN201 in patients with nonsegmental vitiligo.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via